Scientists at Fudan University have developed a novel approach to studying protein glycosylation, a crucial biological process that has been challenging to analyze due to the complexity and scarcity of glycoproteins. The new method, called HG-TCs (Hydrazide-Glycopeptide-Trypsin Cleavage strategy), employs chemical ligation and advanced solid-phase materials to simultaneously identify multiple types of glycosylation.

HG-TCs utilizes an azide-alkyne cycloaddition reaction to enrich glycopeptides and releases them through trypsin cleavage, all within a single tube. This streamlined workflow minimizes sample loss while maintaining high reproducibility. The method's efficiency is demonstrated by its ability to identify over 900 O-GlcNAc sites and 800 N-glycosites in HeLa cells using minimal sample amounts.

The research team highlighted the advantages of their approach, stating, "HG-TCs are very conducive to the study of a highly dynamic and complex carbohydrate system, allowing not only the mapping of multiple glycosylations but also the simultaneous monitoring of multiple glycosylation alterations."

Search Antibodies
Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.

When applied to HeLa cell samples under oxidative stress, the strategy revealed distinct spatial glycosylation patterns between the nucleus and cytoplasm. This finding provides valuable insights into the dynamic roles of glycosylation in cellular responses.

The HG-TCs method, described in National Science Review, represents a significant advancement in glycoproteomics research, offering a more efficient and comprehensive tool for studying glycosylation's role in cellular signaling and disease mechanisms. By simplifying complex workflows while maintaining high data quality, this approach could prove particularly useful in investigating glycosylation alterations in cancer and other diseases.